-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Oseltamivir Acid-[d3]
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/1242184-43-5.gif)
| Category | Influenza Virus |
| CAS | 1242184-43-5 |
| Description | Oseltamivir Acid-[d3] is the labelled analogue of Oseltamivir Acid, which is a metabolite of Oseltamivir. Oseltamivir is an antiviral medication used to treat and prevent influenza A and influenza B. |
Product Information
| Synonyms | Oseltamivir-d3 Acid; (3R,4R,5S)-4-(Acetylamino-d3)-5-amino-3-(1-ethylpropoxy)-1-cyclohexence-1-carboxylic Acid; Oseltamivir-d3 Carboxylic Acid; Oseltamivir carboxylate-d3 |
| IUPAC Name | (3R,4R,5S)-5-amino-3-pentan-3-yloxy-4-[(2,2,2-trideuterioacetyl)amino]cyclohexene-1-carboxylic acid |
| Molecular Weight | 287.37 |
| Molecular Formula | C14H21D3N2O4 |
| Canonical SMILES | CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)O |
| InChI | InChI=1S/C14H24N2O4/c1-4-10(5-2)20-12-7-9(14(18)19)6-11(15)13(12)16-8(3)17/h7,10-13H,4-6,15H2,1-3H3,(H,16,17)(H,18,19)/t11-,12+,13+/m0/s1/i3D3 |
| InChIKey | NENPYTRHICXVCS-HCNPJKKLSA-N |
| Melting Point | >165°C (dec.) |
| Purity | ≥97%; ≥99% atom D |
| Solubility | Slightly soluble in Methanol (Sonicated), Water |
| Appearance | White Solid |
| Storage | Store at -20°C under inert atmosphere |
| Complexity | 391 |
| Exact Mass | 287.19243749 |
| PSA | 105.14000 |
| Target | Influenza A and B |
| XLogP3-AA | -1.9 |
